Alkem unveils ‘affordable’ epilepsy drug

Alkem Laboratories Ltd. has introduced Brivasure, an affordable drug for the treatment of epilepsy in India.

The drug has been introduced at price of ₹ 79.50 per strip for 25 mg, ₹ 148.50 for 50 mg, ₹ 230 for 75 mg and ₹ 295 for a 100-mg strip. Brivasure has been approved by the Drugs Controller General of India in the adjunctive management of partial onset seizure with or without secondary generalization.

Brivasure has exhibited faster onset of action, efficacy with favorable safety profile, the company said.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.


A one-stop-shop for seeing the latest updates, and managing your preferences.


We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

* Our Digital Subscription plans do not currently include the e-paper, crossword and print.

these-vacation-pictures-of-kat-kristian-prove-her-love-for-travelling/ Queen Elizabeth II nailed monochrome dressing PM Modi turns 72; Here’s how India is celebrating his birthday From Avneet Kaur to Mouni Roy: TV celebs’ stylish bikini collections